To alleviate her abdominal pain, she increased her pain medication to 10 tabs of [**Month/Year (2) 10964**] (5 gm/day) and Percocet 2 tabs q3hr (16tab x .325 = 5.2gm).
?s vital signs were temp 97, heart rate 74, blood pressure 98/52, respiratory rate 15, and O2 sat  96% RA.
Her serum acetominophen level, measured approximately 6 hours after overdose, was found to be 220mg/ml.
For her blood sugar of 21, she was given D50W.
A KUB showed increased stool without obstruction.
Labs at OSH included: WBC 14.8  HCT 43, plt 226.
NA 145, K 3.8, Cl 112, HCO3 19, BUN 26,  CR 1.0.
Glucose 21.
AST 1394  ALT 2995  LDH 4039  Ammonia 16.
Urine toxicology screen was positive for Benzo, THC, Prophoxypteme .
Her vital signs were stable.
In the [**Hospital1 18**] ED, she was given acetylcysteine @ 3.2 gm q4h IV, D5W @75cc/hr, and then switched to D10W for a finger stick blood glucose in the 50s.
Urine cultures grew E.coli, and she was started on Ceftriaxone.
No family history of heart disease  Physical Exam: Vitals:   Tm 100.8, HR 66, BP 120/66, RR 12, O2 sat 100RA Gen:	Thin, frail woman lying in bed uncomfortable and in pain.
Liver percusses 8cm in midclavicular line; 3cm below 12th rib.
Registers [**4-15**], recalls 0/3 at 5 mins.
Motor:	 	D	[**Hospital1 **]	Tri		IO	Grip		Q	H	[**Last Name (un) 938**]	G         L	4+	5	5		5	5		5	5	5	5         R	4	4	4		4	4		5	5	5	5  Reflexes: 	[**Hospital1 **]	Tri	BR	Pat	Ach	Plantar         L	2	2	2	2+	2+	no response         R	2+	2+	2+	2+	2+	no response  [**Last Name (un) **]:	intact to LT   Pertinent Results: Admission labs [**2106-3-30**] 05:24AM BLOOD WBC-13.4* RBC-4.51 Hgb-13.4 Hct-40.6 MCV-90 MCH-29.6 MCHC-32.9 RDW-17.5* Plt Ct-189 [**2106-3-30**] 05:24AM BLOOD Neuts-88.3* Bands-0 Lymphs-9.9* Monos-0.4* Eos-1.2 Baso-0.2 [**2106-3-30**] 05:24AM BLOOD Hypochr-NORMAL Anisocy-OCCASIONAL Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-OCCASIONAL Polychr-NORMAL Tear Dr[**Last Name (STitle) 833**] [**2106-3-30**] 05:24AM BLOOD PT-16.2* PTT-26.4 INR(PT)-1.7 [**2106-3-30**] 05:24AM BLOOD Glucose-95 UreaN-21* Creat-0.8 Na-141 K-3.5 Cl-111* HCO3-19* AnGap-15 [**2106-3-30**] 05:24AM BLOOD ALT-2449* AST-1044* LD(LDH)-754* AlkPhos-97 Amylase-62 TotBili-0.8 [**2106-3-30**] 05:24AM BLOOD Albumin-3.7 Calcium-9.0 Phos-2.1* Mg-1.8 [**2106-3-30**] 05:24AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-106.7* Bnzodzp-NEG Barbitr-NEG Tricycl-NEG [**2106-3-30**] 12:02PM BLOOD Type-ART pO2-92 pCO2-33* pH-7.35 calHCO3-19* Base XS--6 KUB:([**3-30**]):No evidence of bowel obstruction or perforation.
Focal narrowing of gas column in transverse colon likely represents peristalsis, although clinical correlation with patient's history is recommended  Labs on transfer to floor [**2106-3-31**] 05:07AM BLOOD WBC-7.6 RBC-3.62* Hgb-10.9* Hct-32.6* MCV-90 MCH-30.0 MCHC-33.3 RDW-17.7* Plt Ct-154 [**2106-3-31**] 05:07AM BLOOD PT-15.4* PTT-28.0 INR(PT)-1.5 [**2106-3-31**] 05:07AM BLOOD Plt Ct-154 [**2106-3-31**] 05:07AM BLOOD Glucose-110* UreaN-10 Creat-0.7 Na-145 K-3.5 Cl-117* HCO3-22 AnGap-10 [**2106-3-31**] 05:07AM BLOOD ALT-1384* AST-195* AlkPhos-82 Amylase-82 TotBili-0.5 [**2106-3-31**] 05:07AM BLOOD Lipase-32 [**2106-3-31**] 05:07AM BLOOD Calcium-8.5 Phos-2.3* Mg-1.5*  ALT/AST 1110/117; hct 33; PT 14 PTT 25 INR 1.4  Bld cx [**3-30**] Urine cx [**3-30**] e coli >100,000   Brief Hospital Course: Patient is a 43 year-old female with a complicated history of multiple sclerosis with a resultant neurogenic bladder and chronic pyelonephritis, who presented approximately 24 hours s/p [**Month/Year (2) 10964**] overdose.
Patient reported that large quantities of [**Month/Year (2) 10964**] were taken for pain control, with no intent of hurting self.
Serum acetominophen at 6 hours 220, 12 hours 107, 18 hours 24.
Liver enzymes were measured q12 hours and steadily improved and NAC was continued until her liver function tests normalized on hospital day #5. normalized within first week of hospitalization.
Amylase and lipase were also monitored, and although nml on admission, reached peaks on [**4-11**] and have subsequently trended down.
Urine culture + for E.coli and Enterococcus.
On day 4, the urine culture was + for E.coli.
On day 7, the urine culture was + enterococcus, and the patient was started on Vancomycin 1000mg IV q12.
Repeat urine cx from [**4-10**] had no growth.
However, given interval increase in pain of RUQ and RLQ repeat abd CT was done on [**4-3**] with evidence of development of colonic wall thickening, involving the transverse colon, splenic flexure, and descending colon, findings that are consistent with colitis.
Stool culture + for c. diff.
Follow up CT on [**4-11**] with diffuse mesenteric and subcutaneous edema.
Unremarkable appearance of small bowel and colon on this examination with no wall thickening and apparent resolution of colitis.
On [**4-14**] she noted inc distention of abd/no BMX3 days and repeat KUB was done to r/u obstruction.
Endoscopy was done at OSH.
Patient remained stable throughout hospital course until evening of [**4-2**] when she experienced inc bloody aspirate from NGT - hct remained stable but GI was consulted for further management.
Given stable hct and recent EGD at OSH, she was managed conservatively with serial hct checks.
This was most likely secondary from hepatic dysfunction -> decrease in glucose production in setting of [**Month/Year (2) **] overdose.
Weight loss.
Will have weekly labs drawn and sent to [**Hospital1 18**] nutrionist/TPN group who will adjust TPN additives as necessary.
Hypotension: pt with baseline SBP in 100's but [**Month (only) **] to 80-90s during admission; min response to fluid bolus - unclear etiology - hct stable despite UGI bleed earlier during admit.
Outpatient Lab Work Please check CBC, Chem-7, glucose, triglycerides, calcium, magnesium, and phosphorus weekly from port-a-cath Please fax results to [**First Name4 (NamePattern1) 553**] [**Last Name (NamePattern1) 18971**] at [**Telephone/Fax (1) **] 3.
Catheter care Catheter care per NEHT protocol 5. heparin flush Heparin 100u/ml, 5mL flush SASH and prn, or QD for line maintenance 6.
[**Telephone/Fax (1) 10964**] overdose 2. complicated UTI 3.
